← Browse by Condition
Medical Condition

nab paclitaxel

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2

ClinicalMetric aggregates all active clinical trials for nab paclitaxel from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

  • Recruiting trials — currently enrolling participants, with eligibility criteria
  • Phase 1–4 studies — from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary for every trial listing
NCT04159142 Phase 2
Recruiting

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer

Enrollment
414 pts
Location
China
Sponsor
Hebei Medical University Fourt...
View Trial →